Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D02KBE
|
||||
| Former ID |
DIB002589
|
||||
| Drug Name |
Ad-OC-hsvTK/valacyclovir
|
||||
| Synonyms |
Ad-OC-hsvTK; Gene therapy (prostate cancer), Winship Cancer Institute; Adenovirus osteocalcin-promoter-driven HSV thymidine Kinase, Winship Cancer Institute; Ad-OC-hsvTK/valacyclovir, Winship Cancer Institute
|
||||
| Indication | Prostate cancer [ICD9: 185; ICD10:C61] | Phase 1 | [546377] | ||
| Company |
Winship Cancer Institute
|
||||
| Target and Pathway | |||||
| Target(s) | Thymidine kinase | Target Info | Inhibitor | [526573] | |
| References | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Tang and Dr. Mou.

